아목시실린 시장 규모는 향후 수년간 안정된 성장이 예상됩니다. 2029년에는 CAGR 3.5%로 56억 3,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 신장 기능장애 증가, 하부 호흡기 감염의 유행, 피부 감염 증가, 하부 호흡기 감염의 사례 증가, 세균 감염의 유행 증가에 기인하고 있습니다. 예측기간의 주요 동향으로는 제네릭 의약품에 대한 수요, 병용요법에 대한 주목, 프로바이오틱스와 면역요법에 대한 관심, 항생제에 대한 수요, 의료시설의 고도화 등이 있습니다.
전염병의 유행 증가는 향후 몇 년 동안 아목시실린 시장의 성장을 이끌 것으로 예상됩니다. 박테리아, 바이러스, 곰팡이, 기생충과 같은 병원성 미생물에 의해 유발되는 감염은 세계 여행, 항균제 내성, 질병 매개 생물에 영향을 미치는 기후 변화, 인구 밀도 상승 등의 요인으로 인해 더욱 널리 사용되고 있습니다. 아목시실린은 박테리아의 세포벽 합성을 표적으로 하고 박테리아 세포를 사멸시킴으로써 이러한 질환의 치료에 효과적입니다. 광범위한 스펙트럼 활성, 신속한 흡수, 다른 항생제와의 상승작용 능력은 다양한 박테리아 감염에 대한 다목적이고 효과적인 치료제가 되었습니다. 예를 들어, 2023년 1월, 미국 국립위생연구소는 요로 감염이 미국에서 응급 외래를 진찰하는 주된 이유의 7위에 랭크되어 연간 100만명 이상이 진찰하고 있다고 보고했습니다. 이 중 22%(22만건)가 복잡성 요로결석으로 분류되어 매년 약 10만건이 입원에 이르고 있습니다. 그 결과 감염증의 유병률 증가가 아목시실린 시장의 성장에 박차를 가하고 있습니다.
헬스케어 지출 증가는 향후 아목시실린 시장의 성장을 가속할 것으로 예상됩니다. 이 지출은 인구의 건강 관리 제공의 전반적인 비용을 반영합니다. 의료비 지출 증가는 첨단 의료 기술 비용 증가, 고령화, 만성 질환의 유병률 증가 때문입니다. 또한 연구개발의 지원도 강화되어 보다 좋은 제제나 항생제의 폭넓은 사용으로 이어질 가능성이 있습니다. 미국 국립보건원은 미국의 의료비가 2022년에 4.1% 증가한 4조 5,000억 달러에 이르렀으며, 2021년의 3.2% 증가에 비해 성장률이 가속되었다고 보고했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염, 그리고 경기 회복이 시장에 미치는 영향을 포함한 거시 경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 아목시실린 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 아목시실린 시장 : 성장률 분석
- 세계의 아목시실린 시장 실적 : 규모와 성장, 2019-2024
- 세계의 아목시실린 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계의 아목시실린 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 아목시실린 시장 : 약제 클래스별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 페니실린
- 세팔로스포린
- 테트라 사이클린
- 마크로라이드
- 술폰아미드
- 세계의 아목시실린 시장 : 치료유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 단제요법
- 병용 요법
- 세계의 아목시실린 시장 : 형태별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 태블릿
- 캡슐
- 서스펜션
- 시럽
- 분말
- 세계의 아목시실린 시장 : 감염 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 피부 감염증
- 이비인후과의 감염증
- 위의 감염증
- 폐 감염증
- 요로 감염(UTI)
- 폐렴
- 기관지염
- 임질
- 세계의 아목시실린 시장 : 최종 사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 홈케어
- 전문 클리닉
- 기타 최종 사용자
- 세계의 아목시실린 시장 : 페니실린유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 페니실린 G
- 페니실린 V
- 광역 스펙트럼 페니실린(아목시실린)
- 베타락탐계 항생제
- 세계의 아목시실린 시장 : 세팔로스포린 하위 세분화, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 제1세대 세파로스포린(세파렉신)
- 제2세대 세팔로스포린(세프록심)
- 제3세대 세팔로스포린(세프토리악손)
- 제4세대 세팔로스포린(세페핌)
- 세계의 아목시실린 시장 : 테트라사이클린 하위 세분화(유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 독시사이클린
- 미노사이클린
- 염산테트라사이클린
- 세계의 아목시실린 시장 : 매크로라이드유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 아지트로마이신
- 에리스로마이신
- 클라리스로마이신
- 세계의 아목시실린 시장 : 술폰아미드별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 설파메톡사졸
- 설파디아진
- 술파살라진
- 트리메토프림과 설파메톡사졸의 배합
제7장 지역별, 국가별 분석
- 세계의 아목시실린 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 아목시실린 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 아목시실린 시장 : 경쟁 구도
- 아목시실린 시장 : 기업 프로파일
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
- Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Merck KGaA
- Teva Pharmaceutical Industries Ltd.
- Alkem Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- CSPC Pharmaceutical Group Limited
- Torrent Pharmaceuticals GmbH
- Aurobindo Pharma Limited
- Hikma Pharmaceuticals PLC
- Intas Pharmaceuticals Ltd.
- Lupin Limited
- Daewoong Pharmaceutical Co. Ltd.
- Centrient Pharmaceuticals
- Wockhardt Limited
- Ranbaxy Laboratories Ltd.
- Atman Pharmaceuticals
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 아목시실린 시장 2029 : 새로운 기회를 제공하는 국가
- 아목시실린 시장 2029 : 새로운 기회를 제공하는 부문
- 아목시실린 시장 2029 : 성장 전략
제36장 부록
SHW
Amoxicillin, a member of the penicillin group, is a broad-spectrum antibiotic used for treating a wide range of bacterial infections. Its mechanism involves inhibiting bacterial growth by preventing the formation of cell walls. This effectively combats infections including respiratory tract infections, urinary tract infections, skin infections, and certain types of bacterial endocarditis.
Amoxicillin belongs to the main drug classes of antibiotics such as penicillins, cephalosporins, tetracyclines, macrolides, and sulfonamides. Penicillins are derived from the Penicillium mold and share a core structure. The drug is available in various formulations including tablets, capsules, suspensions, syrup, and powder. It is used for treating infections such as skin infections, ear, nose, and throat infections, gastrointestinal infections, pulmonary infections, urinary tract infections (UTIs), pneumonia, bronchitis, and gonorrhea. These treatments are utilized across different settings including hospitals, homecare, specialty clinics, and other healthcare facilities.
The amoxicillin market research report is one of a series of new reports from The Business Research Company that provides amoxicillin market statistics, including amoxicillin industry global market size, regional shares, competitors with amoxicillin market share, detailed amoxicillin market segments, market trends and opportunities, and any further data you may need to thrive in the amoxicillin industry. This amoxicillin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The amoxicillin market size has grown steadily in recent years. It will grow from $4.74 billion in 2024 to $4.91 billion in 2025 at a compound annual growth rate (CAGR) of 3.7%. The growth in the historic period can be attributed to an increased understanding of antibiotics, a higher pace of research activities and developments, increased cases of cardiovascular diseases, increased demand for amoxicillin in the treatment of urinary tract infections, rise in the aging population.
The amoxicillin market size is expected to see steady growth in the next few years. It will grow to $5.63 billion in 2029 at a compound annual growth rate (CAGR) of 3.5%. The growth in the forecast period can be attributed to growing impaired renal function, prevalence of lower respiratory infections, increasing skin infections, growing cases of lower respiratory tract infections, and rising prevalence of bacterial infections. Major trends in the forecast period include demand for generic amoxicillin, focus on combination therapies, interest in probiotics and immunotherapy, demand for antibiotics, and advanced healthcare facilities.
The rising prevalence of infectious diseases is anticipated to drive the growth of the amoxicillin market in the coming years. Infectious diseases, caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, are becoming more common due to factors such as global travel, antimicrobial resistance, climate change affecting disease vectors, and higher population density. Amoxicillin is effective in treating these diseases by targeting bacterial cell wall synthesis, leading to bacterial cell death. Its broad-spectrum activity, rapid absorption, and ability to work synergistically with other antibiotics make it a versatile and effective treatment for various bacterial infections. For example, in January 2023, the National Institute of Health reported that urinary tract infections ranked seventh among the leading reasons for emergency department visits in the US, accounting for over 1 million visits annually. Of these, 22% (220,000) were classified as complicated UTIs, with approximately 100,000 cases resulting in hospital admissions each year. Consequently, the increasing prevalence of infectious diseases is fueling the growth of the amoxicillin market.
The increase in healthcare expenditure is expected to drive the growth of the amoxicillin market in the future. Healthcare expenditure refers to the total money spent on healthcare goods and services, including medical treatments, medications, hospitalizations, and preventive care, within a specific period. This expenditure reflects the overall cost of healthcare provision within a population. The rising healthcare expenditures are due to the increasing costs of advanced medical technologies, aging populations, and the prevalence of chronic diseases. Increased healthcare expenditure benefits amoxicillin by ensuring wider accessibility and availability, leading to higher prescription rates and improved patient outcomes. Enhanced funding also supports research and development, potentially leading to better formulations and broader usage of the antibiotic. For example, in January 2024, the National Institutes of Health reported that healthcare expenditure in the US rose by 4.1% in 2022 to reach $4.5 trillion, marking a faster growth rate compared to the 3.2% increase observed in 2021. Thus, the increase in healthcare expenditure is driving the growth of the amoxicillin market.
Major companies in the amoxicillin market are developing innovative drugs, such as reformulated versions of vonoprazan tablets, to enhance the treatment of Helicobacter pylori infections and improve patient outcomes. Vonoprazan is a novel potassium-competitive acid blocker (PCAB), a new class of acid suppressant medication. For example, in May 2022, Phathom Pharmaceuticals, a US-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for VOQUEZNA TRIPLE PAK (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA DUAL PAK (vonoprazan, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection in adults. These treatment regimens include antibiotics conveniently packaged with vonoprazan, a novel potassium-competitive acid blocker (PCAB), marking the first innovative acid suppressant from a new drug class approved in the U.S. in over 30 years.
Major companies operating in the amoxicillin market are Pfizer Inc., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Merck KGaA, Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., CSPC Pharmaceutical Group Limited, Torrent Pharmaceuticals GmbH, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Intas Pharmaceuticals Ltd., Lupin Limited, Daewoong Pharmaceutical Co. Ltd., Centrient Pharmaceuticals, Wockhardt Limited, Ranbaxy Laboratories Ltd., Atman Pharmaceuticals, Sinopharm Weiqida Pharmaceutical Co. Ltd., Cipla Inc., Zydus Cadila
North America was the largest region in the amoxicillin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amoxicillin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the amoxicillin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The amoxicillin market consists of sales of oral formulations, liquid formulations, extended-release tablets, and specialty products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Amoxicillin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on amoxicillin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for amoxicillin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The amoxicillin market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Class: Penicillin; Cephalosporin; Tetracycline; Macrolides; Sulfonamides
- 2) By Therapy Type: Monotherapy; Combinational Therapy
- 3) By Form: Tablets; Capsule; Suspensions; Syrup; Powder
- 4) By Infection Type: Skin Infections; Ear, Nose And Throat Infections; Stomach Infections; Lungs Infections; Urinary tract infections (UTI); Pneumonia; Bronchitis; Gonorrhea
- 5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
- Subsegments:
- 1) By Penicillin: Penicillin G; Penicillin V; Extended-Spectrum Penicillins (Amoxicillin); Beta-Lactam Antibiotics
- 2) By Cephalosporin: First-Generation Cephalosporins (Cephalexin); Second-Generation Cephalosporins (Cefuroxime); Third-Generation Cephalosporins (Ceftriaxone); Fourth-Generation Cephalosporins (Cefepime)
- 3) By Tetracycline: Doxycycline; Minocycline; Tetracycline Hydrochloride
- 4) By Macrolides: Azithromycin; Erythromycin; Clarithromycin
- 5) By Sulfonamides: Sulfamethoxazole; Sulfadiazine; Sulfasalazine; Trimethoprim-Sulfamethoxazole Combination
- Companies Mentioned: Pfizer Inc.; Sanofi S.A.; AstraZeneca Plc; Novartis AG; GlaxoSmithKline Plc
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Amoxicillin Market Characteristics
3. Amoxicillin Market Trends And Strategies
4. Amoxicillin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Amoxicillin Growth Analysis And Strategic Analysis Framework
- 5.1. Global Amoxicillin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Amoxicillin Market Growth Rate Analysis
- 5.4. Global Amoxicillin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Amoxicillin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Amoxicillin Total Addressable Market (TAM)
6. Amoxicillin Market Segmentation
- 6.1. Global Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Penicillin
- Cephalosporin
- Tetracycline
- Macrolides
- Sulfonamides
- 6.2. Global Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Monotherapy
- Combinational Therapy
- 6.3. Global Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tablets
- Capsule
- Suspensions
- Syrup
- Powder
- 6.4. Global Amoxicillin Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Skin Infections
- Ear, Nose And Throat Infections
- Stomach Infections
- Lungs Infections
- Urinary tract infections (UTI)
- Pneumonia
- Bronchitis
- Gonorrhea
- 6.5. Global Amoxicillin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Homecare
- Specialty Clinics
- Other End Users
- 6.6. Global Amoxicillin Market, Sub-Segmentation Of Penicillin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Penicillin G
- Penicillin V
- Extended-Spectrum Penicillins (Amoxicillin)
- Beta-Lactam Antibiotics
- 6.7. Global Amoxicillin Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- First-Generation Cephalosporins (Cephalexin)
- Second-Generation Cephalosporins (Cefuroxime)
- Third-Generation Cephalosporins (Ceftriaxone)
- Fourth-Generation Cephalosporins (Cefepime)
- 6.8. Global Amoxicillin Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Doxycycline
- Minocycline
- Tetracycline Hydrochloride
- 6.9. Global Amoxicillin Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Azithromycin
- Erythromycin
- Clarithromycin
- 6.10. Global Amoxicillin Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Sulfamethoxazole
- Sulfadiazine
- Sulfasalazine
- Trimethoprim-Sulfamethoxazole Combination
7. Amoxicillin Market Regional And Country Analysis
- 7.1. Global Amoxicillin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Amoxicillin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Amoxicillin Market
- 8.1. Asia-Pacific Amoxicillin Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Amoxicillin Market
- 9.1. China Amoxicillin Market Overview
- 9.2. China Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Amoxicillin Market
- 10.1. India Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Amoxicillin Market
- 11.1. Japan Amoxicillin Market Overview
- 11.2. Japan Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Amoxicillin Market
- 12.1. Australia Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Amoxicillin Market
- 13.1. Indonesia Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Amoxicillin Market
- 14.1. South Korea Amoxicillin Market Overview
- 14.2. South Korea Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Amoxicillin Market
- 15.1. Western Europe Amoxicillin Market Overview
- 15.2. Western Europe Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Amoxicillin Market
- 16.1. UK Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Amoxicillin Market
- 17.1. Germany Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Amoxicillin Market
- 18.1. France Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Amoxicillin Market
- 19.1. Italy Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Amoxicillin Market
- 20.1. Spain Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Amoxicillin Market
- 21.1. Eastern Europe Amoxicillin Market Overview
- 21.2. Eastern Europe Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Amoxicillin Market
- 22.1. Russia Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Amoxicillin Market
- 23.1. North America Amoxicillin Market Overview
- 23.2. North America Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Amoxicillin Market
- 24.1. USA Amoxicillin Market Overview
- 24.2. USA Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Amoxicillin Market
- 25.1. Canada Amoxicillin Market Overview
- 25.2. Canada Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Amoxicillin Market
- 26.1. South America Amoxicillin Market Overview
- 26.2. South America Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Amoxicillin Market
- 27.1. Brazil Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Amoxicillin Market
- 28.1. Middle East Amoxicillin Market Overview
- 28.2. Middle East Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Amoxicillin Market
- 29.1. Africa Amoxicillin Market Overview
- 29.2. Africa Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Amoxicillin Market Competitive Landscape And Company Profiles
- 30.1. Amoxicillin Market Competitive Landscape
- 30.2. Amoxicillin Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
31. Amoxicillin Market Other Major And Innovative Companies
- 31.1. Merck KGaA
- 31.2. Teva Pharmaceutical Industries Ltd.
- 31.3. Alkem Laboratories Ltd.
- 31.4. Sun Pharmaceutical Industries Ltd.
- 31.5. CSPC Pharmaceutical Group Limited
- 31.6. Torrent Pharmaceuticals GmbH
- 31.7. Aurobindo Pharma Limited
- 31.8. Hikma Pharmaceuticals PLC
- 31.9. Intas Pharmaceuticals Ltd.
- 31.10. Lupin Limited
- 31.11. Daewoong Pharmaceutical Co. Ltd.
- 31.12. Centrient Pharmaceuticals
- 31.13. Wockhardt Limited
- 31.14. Ranbaxy Laboratories Ltd.
- 31.15. Atman Pharmaceuticals
32. Global Amoxicillin Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Amoxicillin Market
34. Recent Developments In The Amoxicillin Market
35. Amoxicillin Market High Potential Countries, Segments and Strategies
- 35.1 Amoxicillin Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Amoxicillin Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Amoxicillin Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
